Drugs / Decidua Stroma Cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04118556 | Dec 2021 → Apr 2026 | acute graft versus host disease | Mats Remberger | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Decidua Stroma Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04118556 ↗ |
| Known as | DSC | “Decidua Stroma Cells (DSC)” NCT04118556 ↗ |
| Modality | Cell therapy | “The product consists of a viable allogeneic DSCs frozen in 5% of human serum albumin (HSA) in sodium chloride (NaCl) 0.9%” NCT04118556 ↗ |